| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.02 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |